Solutions Catch Fire

Impacts of OTC derivatives regulation and increased corporate actions complexity are being felt, but firms need not despair

michael-shashoua-waters

Regulatory changes affecting over-the-counter (OTC) derivatives trading, after years of gestation following the 2008 financial crisis, are now being felt since starting to take effect in the second half of 2014.

European Market Infrastructure Regulation (EMIR) and actions by the US Commodity Futures Trading Commission, based on the Dodd-Frank Act, will increase operating costs and require firms to re-think their handling of OTC derivatives data, as described in stories in the July issue of Insid

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: